Indegene Limited reported consolidated revenue of ₹10,631 million ($112.5 million) for the quarter ended June 30, 2026, marking a 39.7% year-on-year increase and a 6.0% sequential rise. The growth was driven by an expansion in its active client base to 105, up from 91 in the previous quarter, with 12 customers now generating over $10 million annually. Profit after tax (PAT) surged 45.9% quarter-on-quarter to ₹1,162 million, while EBITDA rose 8.9% sequentially to ₹1,795 million at a 16.9% margin. This performance reflects strong operational leverage and productivity gains, with revenue per employee reaching $77,100.

The Board of Directors approved the unaudited financial results on July 30, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Deloitte Haskins & Sells, the statutory auditor, issued an unmodified opinion on the interim financial information. The company also confirmed that all Initial Public Offer (IPO) proceeds of ₹7,246 million have been fully utilized for repaying indebtedness of subsidiary ILSL Holdings Inc., capital expenditure, technology infrastructure, and general corporate purposes.

Financial Performance

Indegene’s top-line growth was supported by both domestic and international operations, with USD revenue rising 26.5% year-on-year. While net profit remained flat year-on-year at ₹1,162 million compared to ₹1,164 million in Q1FY25, it significantly outperformed the previous quarter’s ₹797 million. Employee benefits expense increased to ₹6,591 million from ₹4,815 million in Q1FY25, reflecting investments in headcount and compensation.

Operational Highlights

The Group operates through two primary segments: Enterprise Medical Solutions and Enterprise Commercial Solutions. Enterprise Commercial Solutions contributed ₹7,502 million, up from ₹5,211 million in Q1FY25, while Enterprise Medical Solutions added ₹2,736 million, rising from ₹2,132 million. Manish Gupta, Chairman and CEO, attributed the success to strengthened sales teams and differentiated AI-powered solutions. Suhas Prabhu, CFO, noted that profitability improved in step with growth, expecting further operating leverage in the second half of FY27 as ongoing engagements scale.

What the Numbers Show

While revenue expanded by nearly 40% year-on-year, net profit remained flat against the prior year due to higher operating expenses, particularly employee benefits which rose by 36.9%. However, the 45.9% sequential jump in PAT indicates improving efficiency. The divergence between flat YoY PAT and robust revenue growth suggests that recent investments in talent and technology are currently absorbing margins, but the sequential improvement in EBITDA and PAT points to emerging operational leverage as the client base scales beyond the 100-active-client milestone.

Indegene Limited has announced the schedule for remote e-voting for its 28th Annual General Meeting (AGM), scheduled for Thursday, August 13, 2026, at 16:30 hours IST via Video Conferencing (VC). The company has fixed Friday, July 31, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹2.25 per equity share of face value ₹2 each for the financial year ended March 31, 2026. The dividend, recommended by the Board on April 29, 2026, is subject to shareholder approval at the AGM.

E-Voting and Participation Details

Shareholders can cast their votes remotely or during the meeting. The remote e-voting period begins at 9:00 a.m. IST on Monday, August 10, 2026, and concludes at 5:00 p.m. IST on Wednesday, August 12, 2026. The cut-off date to determine eligibility for e-voting is Friday, August 7, 2026. Members holding shares on this date are eligible to vote. The facility is provided in compliance with Section 108 of the Companies Act, 2013, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

AGM Agenda

The business to be transacted includes the adoption of audited financial statements for FY 2025-26, the declaration of the final dividend, and the re-appointment of Mr. Manish Gupta and Dr. Sanjay Suresh Parikh as Directors liable to retire by rotation. Additionally, the appointment of Ms. Jill Mary De Simone as an Independent Director for a term of three years is on the agenda.

Financial Performance

The Annual Report for FY 2025-26 highlights consolidated revenue from operations of ₹35,105 million, a growth of 23.6% compared to ₹28,393 million in FY 2024-25. The company reported a Profit After Tax of ₹4,011 million for FY 2025-26. On a standalone basis, revenue stood at ₹12,206 million and profit after tax at ₹2,119 million for the same period.